UTHSC sickle cell researcher on ground floor in latest FDA approvals

By , Daily Memphian Updated: December 16, 2019 4:10 PM CT | Published: December 16, 2019 4:05 AM CT

For years sickle cell has been treated simply with pain medicine, but new research breakthroughs are producing therapies that can really attack the disease and improve lives.

Local business is our business

Bluff City Biz provides you the latest news and developments each week.

Manage Your Email Subscriptions

Topics

Kenneth Ataga sickle cell UTHSC
Jane Roberts

Jane Roberts

Longtime journalist Jane Roberts is a Minnesotan by birth and a Memphian by choice. She's lived and reported in the city more than two decades. She covers healthcare and higher education for The Daily Memphian.


Comment On This Story

Become a subscriber to join the discussion.
Local business is our business

Bluff City Biz provides you the latest news and developments each week.

Manage Your Email Subscriptions